Novel treatment strategies for brain tumors and metastases

Salma E. El-Habashy, Alaa M. Nazief, Chris E. Adkins, Ming M.ing Wen, Amal H. El-Kamel, Ahmed M. Hamdan, Amira S. Hanafy, Tori O. Terrell, Afroz S. Mohammad, Paul R. Lockman, Mohamed I.smail Nounou

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

This review summarizes patent applications in the past 5 years for the management of brain tumors and metastases. Most of the recent patents discuss one of the following strategies: the development of new drug entities that specifically target the brain cells, the blood-brain barrier and the tumor cells, tailor-designing a novel carrier system that is able to perform multitasks and multifunction as a drug carrier, targeting vehicle and even as a diagnostic tool, direct conjugation of a US FDA approved drug with a targeting moiety, diagnostic moiety or PK modifying moiety, or the use of innovative nontraditional approaches such as genetic engineering, stem cells and vaccinations. Until now, there has been no optimal strategy to deliver therapeutic agents to the CNS for the treatment of brain tumors and metastases. Intensive research efforts are actively ongoing to take brain tumor targeting, and novel and targeted CNS delivery systems to potential clinical application.

Original languageEnglish (US)
Pages (from-to)279-296
Number of pages18
JournalPharmaceutical patent analyst
Volume3
Issue number3
DOIs
StatePublished - May 1 2014

Fingerprint Dive into the research topics of 'Novel treatment strategies for brain tumors and metastases'. Together they form a unique fingerprint.

Cite this